| OPMNX | VEXAX | OPMNX / VEXAX | |
| Total Expense Ratio | 1.30 | 0.05 | 2,600% |
| Annual Report Gross Expense Ratio | 1.30 | 0.05 | 2,600% |
| Fund Existence | 25 years | 26 years | - |
| Gain YTD | 6.914 | 13.448 | 51% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.53B | 89.9B | 3% |
| Annual Yield % from dividends | 0.00 | 1.02 | - |
| Returns for 1 year | 4.95 | 29.44 | 17% |
| Returns for 3 years | 23.27 | 66.97 | 35% |
| Returns for 5 years | -6.50 | 31.86 | -20% |
| Returns for 10 years | 12.11 | 184.40 | 7% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FCVT | 54.45 | 0.72 | +1.34% |
| First Trust SSI Strat Convert Secs ETF | |||
| PRF | 53.76 | 0.26 | +0.49% |
| Invesco RAFI US 1000 ETF | |||
| BBHY | 45.99 | 0.04 | +0.09% |
| JPMorgan BetaBuilders $ HY Corp Bnd ETF | |||
| XLCI | 24.21 | -0.40 | -1.65% |
| State Street® CommServSelSectSPDR®PrmETF | |||
| IBRN | 33.81 | -1.60 | -4.52% |
| iShares Neuroscience and Healthcare ETF | |||